Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Neurologic disorders

9,615 views

Published on

Published in: Health & Medicine

Neurologic disorders

  1. 1. Nursing Care of Clients with Neurologic Disorders   Ma. Tosca Cybil A. Torres, RN, MAN
  2. 2. Outline <ul><li>Autoimmune Disorders </li></ul><ul><ul><li>Multiple Sclerosis (MS) </li></ul></ul><ul><ul><li>Myasthenia Gravis (MG) </li></ul></ul><ul><ul><li>Guillen-Barr é syndrome (GBS) </li></ul></ul><ul><li>Degenerative disorders </li></ul><ul><ul><li>Parkinson’s Disease </li></ul></ul><ul><ul><li>Huntington’s Disease </li></ul></ul><ul><ul><li>Amyotrophic Lateral Sclerosis (ALS) </li></ul></ul>
  3. 3. Multiple Sclerosis
  4. 4. Multiple Sclerosis <ul><li>Chronic demyelinating disease of the CNS associated with abnormal immune response to environmental factor </li></ul>
  5. 6. Multiple Sclerosis <ul><li>Periods of exacerbations and remissions </li></ul><ul><li>Progression of disease with increasing loss of function </li></ul><ul><li>Incidence is highest in young adults (20 – 40); onset between 20 – 50 </li></ul><ul><li>Affects females more than males </li></ul><ul><li>More common in temperate climates </li></ul><ul><li>Occurs mainly in Caucasians </li></ul>
  6. 7. Manifestations <ul><li>Fatigue </li></ul><ul><li>Optic nerve involvement: blurred vision, haziness </li></ul><ul><li>nystagmus, dysarthria,cognitive dysfunctions, vertigo, deafness </li></ul><ul><li>Weakness, numbness in leg(s), spastic paresis, bladder and bowel dysfunction </li></ul><ul><li>ataxia </li></ul><ul><li>Spasticity </li></ul><ul><li>Blindness </li></ul>
  7. 8. <ul><li>STRESS AGGRAVATES SYMPTOMS. </li></ul>
  8. 9. Collaborative Care <ul><li>Focus is on retaining optimum functioning and limiting disability </li></ul>
  9. 10. Diagnostic Tests <ul><li>Neurological exam, careful history </li></ul><ul><li>Lumbar puncture with CSF analysis: increased number of T lymphocytes; elevated level of immunoglobulin G (IgG) </li></ul><ul><li>Cerebral, spinal optic nerve MRI: shows multifocal lesions </li></ul><ul><li>Evoked response testing of visual, auditory, somatosensory impulses show delayed conduction </li></ul><ul><li>CT scan shows density of white matter or plaque formation </li></ul>
  10. 11. <ul><li>NO CURE EXISTS FOR MS </li></ul>
  11. 12. Medications <ul><li>Biologic response modifiers </li></ul><ul><ul><li>Interferon beta-1a </li></ul></ul><ul><ul><li>Interferon beta-1b </li></ul></ul><ul><ul><li>Glatiramer acetate </li></ul></ul><ul><li>Glucocorticosteroids </li></ul><ul><li>Immunosuppressants </li></ul><ul><ul><li>azathioprine (Imuran) </li></ul></ul><ul><ul><li>cyclophosphamide (Cytoxan) </li></ul></ul><ul><ul><li>methotrexate </li></ul></ul><ul><li>Muscle relaxants to treat muscle spasms </li></ul><ul><ul><li>diazepam </li></ul></ul><ul><li>Medications to deal with bladder problems: anticholinergics or cholinergics depending on problem experienced by client </li></ul>
  12. 13. Nursing Diagnoses <ul><li>Self care deficit </li></ul><ul><li>Impaired physical mobility </li></ul><ul><li>Risk for injury </li></ul><ul><li>Impaired urinary and bowel elimination </li></ul><ul><li>Impaired verbal communication </li></ul><ul><li>Risk for aspiration </li></ul><ul><li>Disturbed thought processes </li></ul><ul><li>Ineffective individual coping </li></ul><ul><li>Potential for sexual dysfunction </li></ul>
  13. 14. Nursing Care <ul><li>Monitor motor movements for interference with ADLs </li></ul><ul><li>Encourage activity balanced with rest periods </li></ul><ul><li>Assess cognitive function </li></ul><ul><li>Explain: </li></ul><ul><ul><li>Bladder training </li></ul></ul><ul><ul><li>Positioning </li></ul></ul><ul><ul><li>Avoid temperature extremes </li></ul></ul><ul><ul><li>Medication compliance </li></ul></ul><ul><ul><li>Avoid STRESS. </li></ul></ul>
  14. 15. Health Promotion <ul><li>Client needs to develop strategies to deal with fatigue, exacerbations </li></ul><ul><li>Prevention of respiratory and urinary tract infections </li></ul>
  15. 16. Home Care <ul><li>Education </li></ul><ul><li>Referral to support group and resources </li></ul><ul><li>Referral to home health agencies when condition requires </li></ul>
  16. 17. Myasthenia gravis (MG)
  17. 18. Myasthenia gravis (MG) <ul><li>Chronic autoimmune neuromuscular disorder affecting the neuromuscular joint </li></ul>
  18. 20. Myasthenia gravis (MG) <ul><li>characterized by fatigue and severe weakness of skeletal muscles </li></ul><ul><li>Occurs with remissions and exacerbations </li></ul><ul><li>Occurs more frequently in females, with onset between ages 20 – 30 </li></ul>
  19. 21. Manifestations <ul><li>Seen in the muscles that are affected: </li></ul><ul><li>Ptosis (drooping of eyelids), diplopia (double vision) </li></ul><ul><li>Weakness in mouth muscles resulting in dysarthria and dysplagia </li></ul><ul><li>Weak voice, smile appears as snarl </li></ul><ul><li>Head juts forward </li></ul><ul><li>Muscles are weak but DTRs are normal </li></ul><ul><li>Weakness and fatigue exacerbated by stress , fever, overexertion, exposure to heat; improved with rest </li></ul>
  20. 22. <ul><li>MG is purely a MOTOR disorder with no effect on sensation or coordination </li></ul>
  21. 23. Complications <ul><li>Pneumonia </li></ul><ul><li>Myasthenic Crisis </li></ul><ul><li>Sudden exacerbation of motor weakness putting client at risk for respiratory failure and aspiration </li></ul><ul><li>Manifestations: tachycardia, tachypnea, respiratory distress, dysphasia </li></ul>
  22. 24. Complications <ul><li>Cholinergic Crisis </li></ul><ul><li>Occurs with overdosage of medications (anticholinesterase drugs) used to treat MG </li></ul><ul><li>Develops GI symptoms, severe muscle weakness, vertigo and respiratory distress </li></ul><ul><li>Both crises often require ventilation assistance </li></ul>
  23. 25. Diagnostic Tests <ul><li>Physical examination and history </li></ul><ul><li>Tensilon Test: edrophonium chloride (Tensilon) administered and client with myasthenia will show significant improvement lasting 5 minutes </li></ul><ul><li>EMG: reduced action potential </li></ul><ul><li>Antiacetylcholine receptor antibody serum levels: increased in 80% MG clients; used to follow course of treatment </li></ul><ul><li>Serum assay of circulating acetylcholine receptor antibodies: if increased, is diagnostic of MG </li></ul>
  24. 26. Medications <ul><li>Anticholinesterase medications </li></ul><ul><ul><li>Pyridostigmine bromide (Mestinon) </li></ul></ul><ul><li>Immunsuppression medications including glucocorticoids </li></ul><ul><ul><li>Cyclosporineor azathioprine (Imuran) </li></ul></ul>
  25. 27. Surgery <ul><li>Thymectomy is recommended in clients <60 </li></ul><ul><li>Remission occurs in 40 % of clients, but may take several years to occur </li></ul>
  26. 28. Plasmapheresis <ul><li>Used to remove antibodies </li></ul><ul><li>Often done before planned surgery, or when respiratory involvement has occurred </li></ul>
  27. 29. Nursing Care <ul><li>Teaching interventions to deal with fatigue </li></ul><ul><li>Importance of following medication therapy </li></ul>
  28. 30. Nursing Diagnoses <ul><li>Ineffective Airway Clearance </li></ul><ul><li>Impaired Swallowing: plan to take medication to assist with chewing activity </li></ul>
  29. 31. Home Care <ul><li>Avoid fatigue and stress </li></ul><ul><li>Plan for future with treatment options </li></ul><ul><li>Keep medications available </li></ul><ul><li>Carry medical identification </li></ul><ul><li>Referral to support group, community resources </li></ul>
  30. 32. Guillain-Barr é Syndrome (GBS)
  31. 33. Guillain-Barr é Syndrome (GBS) <ul><li>Acute autoimmune inflammatory demyelinating disorder of peripheral nervous system characterized by acute onset of ascending motor paralysis </li></ul>
  32. 34. Guillain-Barr é Syndrome (GBS) <ul><li>Cause is unknown but precipitating events include GI or respiratory infection, surgery, or viral immunizations </li></ul><ul><li>80 – 90% of clients have spontaneous recovery with little or no disabilities </li></ul><ul><li>4 – 6% mortality rate, and up to 10% have permanent disabling weakness </li></ul><ul><li>20 % require mechanical ventilation due to respiratory involvement </li></ul>
  33. 35. Manifestations <ul><li>Most clients have symmetric weakness beginning in lower extremities </li></ul><ul><li>Ascends body to include upper extremities, torso, and cranial nerves </li></ul><ul><li>Sensory involvement causes severe pain, paresthesia and numbness </li></ul><ul><li>Paralysis of intercostals and diaphragmatic muscle </li></ul><ul><li>Autonomic nervous system involvement: blood pressure fluctuations, cardiac dysrhythmias, paralytic ileus, urinary retention </li></ul><ul><li>Weakness usually plateaus or starts to improve in the fourth week with slow return of muscle strength </li></ul>
  34. 36. Diagnostic Tests <ul><li>diagnosis made thorough history and clinical examination; there is no specific test </li></ul><ul><li>CSF analysis: increased protein </li></ul><ul><li>EMG: decrease nerve conduction </li></ul><ul><li>Pulmonary function test reflect degree of respiratory involvement </li></ul>
  35. 37. Medications <ul><li>supportive and prophylactic care </li></ul><ul><li>Antibiotics </li></ul><ul><li>Morphine for pain control </li></ul><ul><li>Anticoagulation to prevent thromboembolic complications </li></ul>
  36. 38. Medical management <ul><li>Tracheostomy </li></ul><ul><li>Plasmapheresis </li></ul><ul><li>Enteral feeding </li></ul><ul><li>IVIG </li></ul>
  37. 39. Nursing Diagnoses <ul><li>Ineffective breathing pattern </li></ul><ul><li>Impaired bed and physical mobility </li></ul><ul><li>Imbalanced nutrition </li></ul><ul><li>Acute Pain </li></ul><ul><li>Risk for Impaired Skin Integrity </li></ul><ul><li>Impaired Communication </li></ul><ul><li>Fear </li></ul>
  38. 40. Nursing Care <ul><li>Maintain respiratory function </li></ul><ul><li>Enhancing physical mobility </li></ul><ul><li>Providing adequate nutrition </li></ul><ul><li>Improving communication </li></ul><ul><li>Decreasing fear and anxiety </li></ul>
  39. 41. Home Care <ul><li>Clients will usually require hospitalization, rehabilitation, and eventually discharge to home </li></ul><ul><li>Client and family will need support; support groups </li></ul>
  40. 42. Degenerative Disorders
  41. 43. Parkinson’s Disease
  42. 44. Parkinson’s Disease <ul><li>Associated with decreased levels of dopamine resulting from destruction of pigmented neuronal cells in the substantia nigra in the basal ganglia. </li></ul>
  43. 45. Parkinson’s Disease <ul><li>characterized by tremor at rest, muscle rigidity and akinesia (poor movement); cause unknown </li></ul><ul><li>Affects older adults mostly, mean age 60 with males more often than females </li></ul><ul><li>Parkinson-like syndrome can occur with some medications, encephalitis, toxins; these are usually reversible </li></ul>
  44. 46. Manifestations <ul><li>Tremor </li></ul><ul><li>at rest with pill rolling motion of thumb and fingers </li></ul><ul><li>Worsens with stress and anxiety </li></ul><ul><li>Progressive impairment affecting ability to write and eat </li></ul><ul><li>Rigidity </li></ul><ul><li>Involuntary contraction of skeletal muscles </li></ul><ul><li>Cogwheel rigidity: jerky motion </li></ul>
  45. 47. Manifestations <ul><li>Akinesia </li></ul><ul><li>Slowed or delayed movement that affects chewing, speaking, eating </li></ul><ul><li>May freeze: loss of voluntary movement </li></ul><ul><li>Bradykinesia: slowed movement </li></ul><ul><li>Posture instability </li></ul><ul><li>Involuntary flexion of head and shoulders, stooped leaning forward position </li></ul><ul><li>Equilibrium problems causing falls, and short, accelerated steps </li></ul><ul><li>Shuffling gait </li></ul>
  46. 49. Manifestations <ul><li>Autonomic nervous system </li></ul><ul><li>Constipation and urinary hesitation or frequency </li></ul><ul><li>Orthostatic hypotension, dizziness with position change </li></ul><ul><li>Eczema, seborrhea </li></ul><ul><li>Depression and dementia; confusion, disorientation, memory loss, slowed thinking </li></ul><ul><li>Inability to change position while sleeping, sleep disturbance </li></ul><ul><li>Mask-like face </li></ul><ul><li>Dysphonia </li></ul>
  47. 50. Complications <ul><li>Impaired communication </li></ul><ul><li>Falls </li></ul><ul><li>Infection related to immobility and pneumonia </li></ul><ul><li>Malnutrition related to dysphagia </li></ul><ul><li>Skin breakdown </li></ul><ul><li>Depression and isolation </li></ul>
  48. 51. Prognosis <ul><li>Slow progressive degeneration </li></ul><ul><li>Eventual debilitation </li></ul>
  49. 52. Diagnostic Tests <ul><li>No specific test for disease </li></ul><ul><li>Drug screens to determine medications or toxins causing parkinsonism </li></ul><ul><li>EEG: slowed and disorganized pattern </li></ul>
  50. 53. Medications <ul><li>Antiparkinsonian- Levodopa (Larodopa) </li></ul><ul><li>antiviral therapy- amantadine (Symmetrel) </li></ul><ul><li>anticholinergics- benztropine mesylate (Cogentin) </li></ul><ul><li>Bromocriptine (Parlodel) pergolide (Permax) inhibit dopamine breakdown </li></ul><ul><li>MAOI- selegiline (Eldepryl) </li></ul><ul><li>Antihistamine- diphenhydramine hydrochloride (Benadryl) </li></ul><ul><li>Medications may lose their efficacy; response to drugs fluctuates: “on-off” effect </li></ul>
  51. 54. Treatments <ul><li>Deep brain stimulation </li></ul><ul><li>Stereotactic procedures </li></ul><ul><li>Pallidotomy: destruction of involved tissue </li></ul><ul><li>thalamotomy: destroys specific tissue involved in tremor </li></ul>
  52. 55. Nursing Diagnoses <ul><li>Impaired Physical Mobility </li></ul><ul><li>Impaired Verbal Communication </li></ul><ul><li>Impaired Nutrition: Less than body requirements </li></ul><ul><li>Self care deficit </li></ul><ul><li>Constipation </li></ul><ul><li>Disturbed Sleep Patterns </li></ul><ul><li>Ineffective coping </li></ul>
  53. 56. Nursing Care <ul><li>Improve mobility </li></ul><ul><li>Enhance self care activities </li></ul><ul><li>Improving bowel elimination </li></ul><ul><li>Improving nutrition </li></ul><ul><li>Enhancing swallowing </li></ul><ul><li>Improving communication supporting coping abilities </li></ul>
  54. 57. Home Care <ul><li>Medication education </li></ul><ul><li>Adaptation of home environment </li></ul><ul><li>Gait training and exercises </li></ul><ul><li>Nutritional teaching </li></ul>
  55. 58. Huntington’s Disease (chorea)
  56. 59. Huntington’s Disease (chorea) <ul><li>Progressive, degenerative inherited neurologic disease characterized by increasing dementia and chorea </li></ul>
  57. 60. Huntington’s Disease (chorea) <ul><li>Cause unknown </li></ul><ul><li>Autosomal dominant genetic disorder </li></ul><ul><li>No cure </li></ul><ul><li>Usually asymptomatic until age of 30 – 40 </li></ul><ul><li>a significant reduction (volume and activity) of acetylcholine </li></ul>
  58. 61. Manifestations <ul><li>Abnormal movement and progressive dementia </li></ul><ul><li>Early signs are personality change with severe depression, memory loss; mood swings, signs of dementia </li></ul><ul><li>Increasing restlessness, worsened by environmental stimuli and emotional stress; arms and face and entire body develops choreiform movements, lurching gait; difficulty swallowing, chewing, speaking </li></ul><ul><li>Slow progressive debilitation and total dependence </li></ul><ul><li>Death usually results from aspiration pneumonia or another infectious process </li></ul>
  59. 62. Diagnostic Tests <ul><li>Genetic testing of blood </li></ul><ul><li>CT scan shows cerebral atrophy </li></ul>
  60. 63. Medications <ul><li>Antipsychotic (phenothiazines and butyrophenones) to block dopamine receptors </li></ul><ul><li>Antidepressants </li></ul>
  61. 64. Nursing Diagnoses <ul><li>Risk for injury </li></ul><ul><li>Risk for Aspiration </li></ul><ul><li>Imbalanced Nutrition: Less than body requirements </li></ul><ul><li>Impaired Skin Integrity </li></ul><ul><li>Impaired Verbal Communication </li></ul><ul><li>Disturbed thought processes </li></ul>
  62. 65. Nursing Care <ul><li>Very challenging: physiological, psychosocial and ethical problems </li></ul><ul><li>Genetic counseling </li></ul>
  63. 66. Home Care <ul><li>Referral to agencies to assist client and family, support group and organization </li></ul>
  64. 67. Amyotrophic Lateral Sclerosis (ALS) Lou Gehrig’s disease
  65. 68. Amyotrophic Lateral Sclerosis (ALS) Disease of unknown cause in which there is a loss of motor neurons in the anterior horns of the spinal cord and the motor nuclei in the lower brain stem.
  66. 69. Amyotrophic Lateral Sclerosis (ALS) <ul><li>Progressive, degenerative neurologic disease characterized by weakness and wasting of muscles without sensory or cognitive changes </li></ul><ul><li>Several types of disease including a familial type </li></ul><ul><li>onset is usually between age of 40 – 60 </li></ul><ul><li>higher incidence in males at earlier ages but equally post menopause </li></ul><ul><li>Physiologic problems involve swallowing, managing secretions, communication, respiratory muscle dysfunction </li></ul><ul><li>Death usually occurs in 2 – 5 years due to respiratory failure </li></ul>
  67. 70. Manifestations <ul><li>Initial: spastic, weak muscles with increased DTRs; muscle flaccidity, paresis, paralysis, atrophy; clients note muscle weakness and fasciculations; muscles weaken, atrophy; client complains of progressive fatigue; usually involves hands, shoulders, upper arms, and then legs </li></ul><ul><li>Atrophy of tongue and facial muscles result in dysphagia and dysarthria; emotional lability and loss of control occur </li></ul><ul><li>50% of clients die within 2 – 5 years of diagnosis, often from respiratory failure or aspiration pneumonia </li></ul>
  68. 71. Diagnostic Test <ul><li>Testing rules out other conditions that may mimic early ALS such as hyperthyroidism, compression of spinal cord, infections, neoplasms </li></ul><ul><li>EMG to differentiate neuropathy from myopathy </li></ul><ul><li>Muscle biopsy shows atrophy and loss of muscle fiber </li></ul><ul><li>Serum creatine kinase if elevated (non-specific) </li></ul><ul><li>Pulmonary function tests: to determine degree of respiratory involvement </li></ul>
  69. 72. Medications <ul><li>Rilutek (Riluzole) antiglutamate </li></ul><ul><ul><li>Prescribed to slow muscle degeneration </li></ul></ul><ul><ul><li>Requires monitoring of liver function, blood count, chemistries, alkaline phosphatase </li></ul></ul>
  70. 73. Nursing Diagnoses <ul><li>Risk for Disuse Syndrome </li></ul><ul><li>Ineffective Breathing Pattern: may require mechanical ventilation and tracheostomy </li></ul>
  71. 74. Nursing Care <ul><li>Help client and family deal with current health problems </li></ul><ul><li>Plan for future needs including inability to communicate </li></ul>
  72. 75. Home Care <ul><li>Education regarding disease, community resources for health care assistance and dealing with disabilities </li></ul>
  73. 76. Creutzfeldt-Jakob disease (CJD, spongiform encephalopathy)
  74. 77. Creutzfeldt-Jakob disease <ul><li>Rapid progressive degenerative neurologic disease causing brain degeneration without inflammation </li></ul>
  75. 78. Description <ul><li>Transmissible and progressively fatal </li></ul><ul><li>Caused by prion protein: transmission of prion is through direct contamination with infected neural tissue </li></ul><ul><li>Variant form of CJD is “mad cow disease”: believed transmitted by consumption of beef contaminated with bovine form of disease </li></ul><ul><li>Pathophysiology: spongiform degeneration of gray matter of brain </li></ul>
  76. 79. <ul><li>No definitive treatment. </li></ul><ul><li>Outcome is fatal. </li></ul>
  77. 80. Manifestations <ul><li>Onset: memory changes, exaggerated startle reflex, sleep disturbances </li></ul><ul><li>Rapid deterioration in motor, sensory, language function </li></ul><ul><li>Confusion progresses to dementia </li></ul><ul><li>Terminal states: clients are comatose with decorticate and decerebrate posturing </li></ul>
  78. 81. Diagnostic Tests <ul><li>Clinical pictures, suggestive changes on EEG and CT scan </li></ul><ul><li>Similar to Alzheimers in early stages </li></ul><ul><li>Final diagnosis made on postmortem exam </li></ul>
  79. 82. Nursing Care <ul><li>Use of standard precautions with blood and body fluids </li></ul><ul><li>Support and assistance to client and family </li></ul>
  80. 83. Trigeminal neuralgia (tic douloureux)
  81. 84. Description <ul><li>Chronic disease of trigeminal nerve (cranial nerve V) causing severe facial pain </li></ul><ul><li>The maxillary and mandibular divisions of nerve are effected </li></ul><ul><li>Occurs more often in middle and older adults, females more than males </li></ul><ul><li>Cause is unknown </li></ul>
  82. 85. Manifestations <ul><li>Severe facial pain occurring for brief seconds to minutes hundreds of times a day, several times a year </li></ul><ul><li>Usually occurs unilaterally in area of mouth and rises toward ear and eye </li></ul><ul><li>Wincing or grimacing in response to the pain </li></ul><ul><li>Trigger areas on the face may initiate the pain </li></ul><ul><li>Sensory contact or eating, swallowing, talking may set off the pain </li></ul><ul><li>Often there is spontaneous remission after years, and then condition recurs with dull ache in between pain episodes </li></ul>
  83. 86. Diagnosis <ul><li>by physical assessment </li></ul>
  84. 87. Medications <ul><li>Anticonvulsants </li></ul><ul><li>carbamazepine (Tegretol) </li></ul><ul><li>phenytoin (Dilantin) </li></ul><ul><li>gabapentin (Neurotin) </li></ul>
  85. 88. Surgery <ul><li>Intractable pain may be treated by severing the nerve root: rhizotomy </li></ul><ul><li>Client may have lost facial sensation and have loss of corneal reflex </li></ul>
  86. 89. Nursing Care <ul><li>Teaching client self-management of pain </li></ul><ul><li>Maintaining nutrition </li></ul><ul><li>Preventing injury </li></ul>
  87. 90. Bell’s Palsy
  88. 91. Description <ul><li>Disorder of seventh cranial nerve and causes unilateral facial paralysis </li></ul><ul><li>Occurs between age of 20 – 60 equally in males and females </li></ul><ul><li>Cause unknown, but thought to be related to herpes virus </li></ul>
  89. 92. Manifestations <ul><li>Numbness, stiffness noticed first </li></ul><ul><li>Later face appears asymmetric: side of face droops; unable to close eye, wrinkle forehead or pucker lips on one side </li></ul><ul><li>Lower facial muscles are pulled to one side; appears as if a stroke </li></ul>
  90. 93. Prognosis <ul><li>Majority of person recover fully in few weeks to months </li></ul><ul><li>Some persons have residual paralysis </li></ul>
  91. 94. Diagnosis <ul><li>based on physical examination </li></ul>
  92. 95. Collaborative Care <ul><li>Corticosteroids are prescribed in some cases but use has been questioned </li></ul><ul><li>Treatment is supportive </li></ul>
  93. 96. Nursing Care <ul><li>Teaching client self-care: prevent injury and maintain nutrition </li></ul><ul><li>Use of artificial tears, wearing eye patch or taping eye shut at night; wearing sunglasses </li></ul><ul><li>Soft diet that can be chewed easily, small frequent meals </li></ul>

×